StockData
Obsidian Therapeutics, Inc. logo

Obsidian Therapeutics, Inc. (OBX) stock

OBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$12.00−0.15 (-1.23%)

Close on Nov 20, 2026Market cap $741.28MP/E –Yield –

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Leverage and liquidity

Current ratio12.29vs 3.31
Quick ratio17.76vs 2.39

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

21.17
DistressSafe

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 20, 2026

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

43
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

OBXS&P 500
PeriodOBXS&P 500DifferenceOBX per yearS&P 500 per year
1 month-9.4%-10.3%+0.9 pts
3 months-40.6%-9.3%−31.2 pts

How much it moves

Volume against its 90-day average0.81vs 0.98

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M OBX shares were sold short on Oct 30, 2026, up 9.6% from the previous report, or 1.92% of the shares available to trade. At recent volumes it would take 3.9 days to buy them back. Over the last 20 sessions, 60.3% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float1.92%vs 9.12%
Short interest as a share of all shares1.92%vs 6.45%
Days of volume to buy it back3.94vs 5.40

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,184,895+9.6%300,5533.9
Oct 15, 20261,081,550+22.3%336,3433.2
Sep 30, 2026884,528+249.5%1,019,1811.0
Sep 15, 2026253,084+210.7%314,7391.0
Aug 31, 202681,457+125.6%227,7681.0
Aug 14, 202636,102–46,6581.0

Every measure, in full

34 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 20, 2026

Valuation ratiosIndustry

Market Cap
$741.28M
$247.72M
Enterprise Value
$416.88M
$126.71M
PB Ratio
2.31
1.88
P/TBV Ratio
2.31
2.12

Share statisticsIndustry

Shares Change (QoQ)
6177300.0%
0.58%
Float
62M
49M
Shares Held by Insiders
0.05%
11.4%

Short sellingIndustry

Short Interest
1M
–
Short Interest Change
9.56%
-0.61%
Short % of Float
1.92%
9.12%
Short % of Shares Outstanding
1.92%
6.45%
Days to Cover
3.94
5.40

Stock price statisticsIndustry

20-Day Moving Average
$13.01
–
50-Day Moving Average
$13.71
–
Average True Range (14)
$1.41
–
Price Change (1 Week)
-4.46%
-10.2%
Price Change (1 Month)
-13.9%
-14.0%
Price Change (3 Months)
-35.8%
-31.5%
Average Volume (10 Days)
558,343
–
Average Volume (20 Days)
598,829
–
Average Volume (90 Days)
415,682
–
Relative Volume
0.81
0.98
Relative Strength Index (14)
43.2
36.4

Financial positionIndustry

Current Ratio
12.29
3.31
Quick Ratio
17.76
2.39

Balance sheetIndustry

Net Cash (Debt)
$324.40M
$15.80M
Net Cash Per Share
$5.25
$0.76
Equity (Book Value)
$320.58M
$49.40M
Book Value Per Share
$5.19
$1.49
Tangible Book Value
$320.58M
$23.91M
Working Capital
$206.27M
$74.41M

Scores and fair valueIndustry

Altman Z-Score
21.17
0.23

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?